Data were extracted from original study manuscripts and from reviews with detailed quantitative results of the pharmacokinetic endpoints of interest
Comparing with Symptoms: They compare the test results with the patients symptoms and history to determine if the pain is related to semaglutide or another cause
Doctors who Science News talked to for this story emphasized the significance of the recent MASH progress, calling this era in the field a watershed moment, and the more than a dozen new medications in development a tidal wave. Rezdiffra may have been the first drug FDA-approved for MASH, but in the next two to three years, Su says, there will be many more
Written informed consent for clinical data use was obtained from the patient
However, its potential benefits in improving cardiovascular (CV) risk factors have yet to be determined
What medications should not be taken with semaglutide